Current techniques in wound healing modulation in glaucoma surgery

P T Khaw1, C S Migdal

  • 1Glaucoma Unit, Moorfields Eye Hospital London, UK.

Insights

Antiscarring agents like 5-fluorouracil and mitomycin C improve glaucoma surgery outcomes by controlling wound healing. Optimizing their use is key to minimizing side effects and achieving target intraocular pressure.

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Glaucoma Research

Background:

  • Wound healing significantly impacts intraocular pressure (IOP) post-glaucoma surgery.
  • Antimetabolites, including 5-fluorouracil and mitomycin C, have transformed glaucoma surgical procedures.
  • Achieving optimal IOP reduction is crucial for all glaucoma surgery patients.

Purpose of the Study:

  • To review recent advancements in antiscarring agents for glaucoma surgery.
  • To outline the current state-of-the-art in managing wound healing post-surgery.
  • To provide insights on optimizing surgical outcomes and minimizing adverse effects.

Main Methods:

  • Literature review of recent publications on antiscarring agents in glaucoma surgery.
  • Analysis of current strategies for wound healing modulation.
  • Evaluation of the efficacy and safety profiles of antimetabolites.

Main Results:

  • Antimetabolites are vital for controlling wound healing and achieving target IOP.
  • Despite benefits, antimetabolites present potential sight-threatening complications.
  • Current research focuses on balancing efficacy with safety in glaucoma surgery.

Conclusions:

  • Effective wound healing management is paramount for successful glaucoma surgery.
  • Careful application of antimetabolites is necessary to mitigate risks.
  • Ongoing research aims to refine antiscarring strategies for improved patient outcomes.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...